Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1165450-70-3

Post Buying Request

1165450-70-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1165450-70-3 Usage

General Description

(4R)-4-(hydroxyMethyl)-2-Pyrrolidinone is a chemical compound that belongs to the class of pyrrolidinones. It is a colorless to pale yellow liquid with a faint odor, and it is soluble in water and most organic solvents. (4R)-4-(hydroxyMethyl)-2-Pyrrolidinone has various industrial uses, including as a solvent, a corrosion inhibitor, a reactive diluent in radiation-curable coatings, and a monomer in the production of polyvinylpyrrolidone (PVP). It is also used in the synthesis of pharmaceuticals and agrochemicals. Additionally, (4R)-4-(hydroxyMethyl)-2-Pyrrolidinone has potential applications in the production of polymers, resins, and adhesives. (4R)-4-(hydroxyMethyl)-2-Pyrrolidinone is considered to have low toxicity and is generally regarded as safe for use in specific applications, with proper handling and storage precautions.

Check Digit Verification of cas no

The CAS Registry Mumber 1165450-70-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,5,4,5 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1165450-70:
(9*1)+(8*1)+(7*6)+(6*5)+(5*4)+(4*5)+(3*0)+(2*7)+(1*0)=143
143 % 10 = 3
So 1165450-70-3 is a valid CAS Registry Number.

1165450-70-3Relevant articles and documents

3,4-Methano-β-proline: A conformationally constrained β-amino acid

Medda, Amiya Kumar,Lee, Hee-Seung

, p. 921 - 924 (2009)

An enantiomerically pure, conformationally constrained β-proline derivative, 3,4-methano-β-proline, was synthesized starting with a readily available bicyclic lactone by using a straightforward synthetic route.

SUBSTITUTED NAPHTHYRIDINES AND THEIR USE AS SYK KINASE INHIBITORS

-

Page/Page column 46, (2011/08/21)

The invention relates to new substituted naphthyridines of formula (1), as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein R1 is selected from among -O-R3 or -NR3R4, R3 is C1-6-alkyl which is substituted by R5 and R6 R5 is selected from hydrogen, branched or linear C1-6-alkyl, C2-6-alkenyl, -C1-6-alkylen-O-C1-3-alkyl, C1-3-haloalkyl, R6 is ring X wherein n is either 0 or 1, and Formula (I) is a either a single or a double bond and wherein A, B, D and E are each independently from one another selected from CH2, CH, C, N, NH, O or S and wherein ring X is attached to the molecule either via position A, B, D or E, wherein said ring X may optionally be further substituted by one, two or three residues each selected individually from the group consisting of -oxo, hydroxy, -C1-3-alkyl, -C1-3-haloalkyl, -O-C1-3-alkyl, -C1-3-alkanol and halogen, and wherein R4, R2, R7, R8, R9, R10, R11 and Q may have the meanings as given in claim 1, as well as pharmaceutical compositions containing these compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1165450-70-3